Related by context. All words. (Click for frequent words.) 75 Golimumab 75 Romiplostim 74 Methylnaltrexone 74 Dasatinib 74 Apixaban 74 atypical Hemolytic Uremic Syndrome 74 Aflibercept 74 Enzyme Replacement Therapy 74 Epratuzumab 73 Tocilizumab 73 etanercept Enbrel 73 TNF Tumor Necrosis Factor 73 Enzastaurin 73 Certolizumab pegol 72 Daclizumab 72 Aliskiren 72 docetaxel Taxotere ® 72 Meets Primary Endpoint 72 infliximab Remicade 72 Boceprevir 72 Patients Treated With 72 Atypical Hemolytic Uremic Syndrome 72 Naive Patients 72 PKC# 72 erlotinib Tarceva ® 72 PEGylated Fab fragment 72 R lenalidomide 72 thalidomide Thalomid 72 Afatinib 71 Teriflunomide 71 basiliximab 71 Lupus Nephritis 71 Pegloticase 71 FASLODEX 71 Bosutinib 71 Phase 2b Clinical Trial 71 IL# PE#QQR 71 Pegylated 71 INSPIRE Trial Phase III 71 Placebo Controlled Study 71 Rilonacept 71 Tezampanel 71 Long Term Efficacy 71 Safinamide 71 Fondaparinux 71 benign prostatic hypertrophy BPH 71 Desvenlafaxine 71 aripiprazole Abilify 71 Pirfenidone 71 Bucindolol 71 Teriparatide 71 methylnaltrexone bromide 71 adalimumab Humira 71 sorafenib tablets 71 Dalbavancin 71 Prolongs Survival 71 Bevacizumab 71 Progressive Multifocal Leukoencephalopathy 71 oral dual endothelin 71 Temsirolimus 71 Oral Fingolimod 71 Antitumor Activity 71 Vidofludimus 71 fosbretabulin 71 CYT# potent vascular disrupting 71 NAVISTAR R 70 sorafenib Nexavar 70 Radioimmunotherapy 70 metastatic colorectal 70 Personalized Immunotherapy 70 dual endothelin receptor antagonist 70 Adalimumab 70 Advanced Melanoma 70 PEGylated anti 70 Demonstrates Efficacy 70 phase III isavuconazole 70 MAGE A3 ASCI 70 Pivotal Clinical Trial 70 Phase III Clinical Trial 70 Epidermal Growth Factor Receptor 70 Pivotal Study 70 Noxafil 70 Pulmonary Arterial Hypertension 70 Denufosol 70 Improves Outcomes 70 Renal Cell Carcinoma 70 Vandetanib 70 Nebulized 70 Hepatocellular Carcinoma 70 Liprotamase 70 Myelofibrosis 70 Lubiprostone 70 myelofibrosis polycythemia vera 70 Deforolimus 70 Pertuzumab 70 Patients Receiving 70 Adjuvant Treatment 70 R Saizen R 70 Myelodysplastic Syndrome 70 Randomized Double blind 70 Degarelix 70 Pivotal Phase III 70 Hepatocellular Carcinoma HCC 70 Tacrolimus 70 kidney urologic 70 GW# [003] 70 Intravesical 70 Investigational Treatment 70 Carfilzomib 70 Interferon Beta 70 Sapacitabine 70 Dacogen decitabine 70 Immunogenic 70 Dose Ranging Study 70 Ridaforolimus 70 Belimumab 70 Bortezomib 70 dyskinesia PD LID 70 targeted radiotherapeutic 70 Pooled Analysis 70 receptor tyrosine kinase inhibitor 70 Zarnestra 70 Pemetrexed 70 sunitinib Sutent ® 69 Elotuzumab 69 Muraglitazar 69 Nitazoxanide 69 dasatinib Sprycel ® 69 Autologous Stem Cell Transplantation 69 Phase 2a Clinical Trial 69 Renal Impairment 69 Everolimus 69 myelodysplastic myeloproliferative diseases 69 Phase III Trial 69 Zorbtive TM 69 gastrointestinal stromal tumors GIST 69 Voreloxin 69 Anti Tumor 69 Shows Efficacy 69 Peginterferon alfa 2b 69 Adjuvant Chemotherapy 69 Sipuleucel T 69 Previously Treated 69 Silodosin 69 Alemtuzumab 69 sunitinib Sutent 69 Romidepsin 69 Pazopanib 69 Alequel 69 Tigecycline 69 Psoriasis Drug 69 Dapagliflozin 69 Pivotal Trial 69 Etanercept 69 Mitoxantrone 69 Neoadjuvant 69 ACE Inhibitors 69 MYCAMINE 69 Mycophenolate Mofetil 69 atypical hemolytic uremic syndrome 69 SinuNase TM 69 Treated Patients 69 acute humoral rejection 69 STELARA TM 69 Granulocyte Colony Stimulating Factor 69 Ozarelix 69 cediranib 69 metastatic malignant 69 Vidaza azacitidine 69 Paraplatin ® 69 Trastuzumab 69 Infected Patients 69 Study Evaluating 69 NASH Huntington 69 Advanced Renal Cell 69 Metastatic Prostate Cancer 69 Anti VEGF 69 Immunotherapeutic 69 Initiate Clinical Trial 69 Cholesterol Lowering Drug 69 Acute Ischemic Stroke 69 RhuDex 69 Aviptadil 69 Warfarin Coumadin 69 Faropenem 69 Ofatumumab 69 Gemzar ® 69 Bazedoxifene 69 Ocrelizumab 69 metastatic neuroendocrine tumors 69 Efficacy Trial 69 Investigational Compound 69 Vicriviroc 69 MKC# MKC# PP 69 II Clinical Trial 69 Chronic Sinusitis 69 hormone LHRH antagonist 69 Hepatotoxicity 69 Refractory Hodgkin Lymphoma 69 Xelox 69 Anthracycline 69 Myelodysplastic Syndromes 69 alfa 2a 69 Skeletal Muscle 69 GTC recombinant human 69 investigational pharmacologically unique 69 Phase IIb Trial 69 Ribavirin causes 69 BARACLUDE ® 69 Investigational Drug 69 hypereosinophilic syndrome 69 Malignant Melanoma 69 Complicated Skin 69 Severe Sepsis 69 bevacizumab Avastin 69 Sustained Efficacy 69 vapreotide acetate 69 Novel Oral 69 Hsp# Inhibitor 69 Panzem R 69 mertansine 69 bevacizumab Avastin ® 69 Levoleucovorin 69 Intravitreal 69 rituximab Rituxan 69 Improves Survival 69 SYN# 69 Calcitonin 69 lucinactant 69 Talabostat 69 Arimoclomol 68 chimeric monoclonal antibody 68 Glatiramer Acetate 68 Overactive Bladder 68 proteasome inhibitor 68 lexidronam injection 68 Pafuramidine 68 Aryplase 68 Telbivudine 68 Demonstrates Sustained 68 Microplasmin 68 Omalizumab 68 oral Janus kinase 68 Tanespimycin 68 ZOLINZA 68 Well Tolerated 68 HQK 68 AA Amyloidosis 68 Improved Survival 68 Traficet EN 68 Tolvaptan 68 MKC# MT 68 SNT-MC#/idebenone 68 Metastatic Colorectal Cancer 68 Heart Failure Patients 68 rFVIIa 68 Rivaroxaban 68 HER2 Positive Breast Cancer 68 YONDELIS 68 Ataluren 68 TYZEKA 68 Carbamazepine 68 BAY #-# 68 Microalbuminuria 68 abacavir Ziagen 68 Fluconazole 68 Paroxysmal Nocturnal Hemoglobinuria PNH 68 Bendamustine 68 Natalizumab 68 efalizumab 68 Expanded Indication 68 Granted Orphan Drug 68 Mouse Model 68 Clolar ® 68 Anti Tumor Activity 68 Actemra tocilizumab 68 Kuvan sapropterin dihydrochloride 68 Soft Tissue Sarcoma 68 Mitomycin C 68 Clinical Trial Results 68 somatostatin analogue 68 Cyclooxygenase 2 68 Sudhir Agrawal D.Phil 68 Nilotinib 68 Initiates Enrollment 68 familial amyloidotic polyneuropathy FAP 68 Initiates Clinical Trial 68 Regenerative Cells 68 RhuDex ® 68 invasive candidiasis 68 Corticosteroids 68 Moxifloxacin 68 pan HDAC inhibitor 68 HCV Protease Inhibitor 68 Cariprazine 68 Glufosfamide 68 Mipomersen 68 INTEGRILIN R 68 imatinib Gleevec ® 68 ZACTIMA 68 PEGINTRON TM 68 lenalidomide Revlimid R 68 Abatacept 68 RNAi Therapeutic 68 Maribavir 68 Azathioprine 68 Alinia 68 Fungal Infections 68 IV Busulfex 68 Nexavar ® 68 Omacetaxine 68 Vildagliptin 68 Dupuytren Contracture 68 acyclovir Lauriad R 68 PEG SN# 68 Investigational Agent 68 Preclinical Study 68 FOLOTYN ® 68 Glioblastoma Multiforme 68 ORENCIA R 68 Diabetic Nephropathy 68 protein tyrosine phosphatase 1B 68 Prospective Randomized 68 Myocet 68 Fludarabine 68 Intravascular 68 gefitinib Iressa 68 Tyrosine Kinase Inhibitor 68 topically applied SEPA 68 esophageal candidiasis 68 Progenitor Cells 68 Vitrasert R 68 Aclidinium 68 Single Dose 68 Melphalan 68 Double Blind Placebo 68 Myelodysplastic Syndrome MDS 68 Aprotinin 68 Interferon Alpha 68 Mucosal 68 Ischemic 68 Minimally Invasive Procedure 68 Acute Attacks 68 Combination REOLYSIN R 68 Patients Undergoing 68 ACTEMRA TM 68 Mg Uk 68 Eltrombopag 68 Therapeutic Vaccine 68 octreotide acetate 68 Ecallantide 68 Azacitidine 68 AVASTIN 68 selective modulator 68 Bisphosphonate 68 Anidulafungin 68 recurrent glioblastoma multiforme 68 Toxicities 68 catheter occlusion 68 Shows Promise Against 68 FDA APPROVES 68 LymphoStat B belimumab 68 Dabigatran etexilate 68 xanthine oxidase inhibitor 68 SPRYCEL ® 68 Irinotecan 67 Effectively Treats 67 Combination Treatment 67 Parkinson disease levodopa induced 67 Tesamorelin 67 Allogeneic 67 Cutaneous T 67 Transdermal Patch 67 Acute Exacerbations 67 Vascugel 67 Fludara ® 67 Treating Chronic 67 Aztreonam lysine 67 Antitumor 67 Refractory Angina 67 Eraxis 67 Completes Patient Enrollment 67 Demonstrate Significant 67 Elagolix 67 Fabry Disease 67 FDA Approvals 67 KRN# 67 ADP receptor antagonist 67 Adjunctive Therapy 67 Anticoagulant 67 Rheumatoid Arthritis Patients 67 Phase 2b Study 67 TNF Blockers 67 Fluorouracil 67 Phase III Pivotal 67 tigecycline 67 denileukin diftitox 67 TORISEL 67 peripherally acting 67 See CLINICAL PHARMACOLOGY 67 Phase 2a Trial 67 evaluating tivozanib 67 intravesical infusion therapy 67 cetuximab Erbitux ® 67 Gefitinib 67 Occlusive Disease 67 IgG1 monoclonal antibody 67 Inhalation Powder 67 Sevelamer 67 Survival Benefit 67 Mirapexin 67 Belatacept 67 Appears Safe 67 Crizotinib 67 PD LID 67 cisplatin gemcitabine 67 B Cell Lymphoma 67 relapsed MM 67 Relapsed Refractory 67 Leukemias 67 Relapsing Multiple Sclerosis 67 Indomethacin 67 Plaquenil 67 galiximab 67 Chronic Lymphocytic Leukemia 67 Adenoviral 67 treat benign prostatic 67 Valsartan 67 TLK# 67 Chronic Lymphocytic Leukemia CLL 67 Hematopoietic 67 basal bolus regimen 67 oral prodrug 67 Demonstrates Positive 67 Newly Diagnosed Multiple Myeloma 67 Sorafenib 67 Relapsing Remitting Multiple Sclerosis 67 Eszopiclone 67 ELADUR ™ 67 ALVESCO R 67 Metastatic Melanoma 67 Peripheral Arterial 67 Monotherapy 67 Lambert Eaton Myasthenic 67 essential thrombocythemia ET 67 INCB# [003] 67 Small Molecule 67 Lung Cancer Drug 67 Navelbine ® 67 Daptomycin 67 Tiotropium 67 Torisel 67 Medidur ™ FA 67 Multiple Myeloma Patients 67 FUSILEV enhances 67 lapatinib Tykerb 67 endoluminal stent graft 67 Phase III Trials 67 JAK Inhibitor 67 R sorafenib tablets 67 TACI Ig 67 Acute Radiation Syndrome ARS 67 Kinase Inhibitor 67 Prochymal TM 67 MGd 67 Diffuse Large B 67 Relapsed Multiple Myeloma 67 Drug Candidate 67 Pharmacokinetic Study 67 Decitabine 67 Radiofrequency Ablation RFA 67 Improve Survival 67 CIMZIA R 67 mild vasodilator 67 immunosuppressant drug 67 complement inhibitor eculizumab 67 delivers fluocinolone acetonide FA 67 ORENCIA ® 67 Patient Enrollment 67 Mg Usa 67 Bezielle 67 malignant ascites 67 Diabetic Macular Edema DME 67 invasive aspergillosis 67 Trial Evaluating 67 Renal Cancer 67 Antigen Specific 67 Simulect 67 Pioglitazone 67 idiopathic thrombocytopenic purpura ITP 67 Peginterferon 67 Invasive Fungal Infections 67 Known hypersensitivity 67 Campath ® 67 opioid induced constipation OIC 67 Febuxostat 67 Olaparib 67 Ixabepilone 67 Cetrorelix 67 Syncria R 67 ® lenalidomide 67 immunomodulatory agents 67 Certolizumab 67 Tekmira LNP technology 67 Chemoradiation 67 ARIXTRA R 67 Antiangiogenic 67 Cardiotoxicity 67 Receives Orphan Drug Designation 67 cilengitide 67 Plasmin 67 Phase 2b Trial 67 Lenalidomide 67 Drug Shows Promise 67 Novel Antibiotic 67 Ixempra 67 pertuzumab 67 haloperidol Haldol 67 Hormone Refractory Prostate Cancer 67 soluble tumor necrosis 67 Deferiprone 67 Blinatumomab 67 Fulvestrant 67 Humanized Anti 67 Cannabinor 67 Cyclosporin 67 mu opioid receptor antagonist 67 Septic Shock 67 Plaque Psoriasis 67 riociguat 67 BENICAR HCT 67 Metabolic Disorder 67 Liver Failure 67 First Patient Enrolled 67 Angioedema 67 Archexin 67 Wafer polifeprosan 67 Nexavar sorafenib 67 occlusion PAO 67 Androgen Deprivation Therapy 67 Shows Promising 67 nephropathic cystinosis 67 Endologix Powerlink System 67 C1 Inhibitor 67 bortezomib Velcade 67 beta 1a 67 cromolyn sodium 67 humanised monoclonal antibody 67 PEGylated interferon beta 1a 67 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 67 EOquin TM phase 67 HMG CoA reductase inhibitors 67 Gleevec resistant 67 Treatment Regimen 67 Tumor Response 67 BARACLUDE R 67 Ranolazine 67 Hematologic 67 Zileuton 67 Acute Decompensated Heart Failure 67 Tarceva TM 67 Contrast Agent 67 Aurora Kinase 67 Factor VIIa 67 UPLYSO 67 Serostim ® 67 Reduces Mortality 67 Shows Statistically Significant 67 Ganciclovir 67 Preclinical Data 67 Antiplatelet 66 AFREZZA TM 66 Fibrin Pad 66 diarrhea predominant irritable 66 Ovitrelle R Serostim 66 Treatment Naive Patients 66 Kidney Transplant Patients 66 Rasagiline 66 Infliximab 66 Squalamine 66 antibody MAb 66 Philadelphia Chromosome Positive 66 Systemic lupus erythematosus 66 Dementia Related Psychosis 66 Pralatrexate 66 Bivalirudin 66 Etravirine 66 Prostate Cancer Vaccine 66 sertraline Zoloft 66 Cyclosporine 66 Cethrin R 66 acetonide FA 66 Yondelis ® 66 Humate P 66 tyrosine kinase inhibitor 66 HepaLife TM 66 Metastatic Renal Cell Carcinoma 66 Pulmonary Arterial Hypertension PAH 66 mTOR inhibitor 66 Cytotoxic 66 Cleviprex TM clevidipine 66 mapatumumab 66 Tasigna nilotinib 66 ISTODAX ® 66 SomatoKine 66 itraconazole Sporanox 66 lanreotide 66 Albuferon TM 66 RoACTEMRA 66 Gliadel Wafer 66 PDX pralatrexate 66 Fx #A 66 Bevacizumab Avastin 66 disease GERD 66 Rheumatoid 66 Renal Function 66 acute peripheral arterial 66 Combo Therapy 66 Lymphoid 66 direct thrombin inhibitors 66 Tesetaxel 66 Analgesic 66 Thiazolidinediones 66 Antithrombin 66 Recombinant Human 66 Amrubicin 66 superficial bladder cancer 66 Antiviral Activity 66 radiation sensitizer 66 ibuprofen Injection 66 5 Fluorouracil 66 5 HT4 66 Toremifene 66 Advanced Colorectal Cancer 66 Solid Tumors 66 rotigotine transdermal patch 66 BANZEL 66 Prophylactic Treatment 66 Luteinizing Hormone Releasing Hormone 66 Retinoic Acid 66 Sodium oxybate 66 dasatinib Sprycel 66 refractory gout 66 Fluvastatin 66 Leber Hereditary Optic Neuropathy 66 Electronic Brachytherapy System 66 targeted antifolate 66 investigational monoclonal antibody 66 Diabetic Neuropathy 66 chronic eosinophilic leukemia 66 Ramelteon 66 cetuximab Erbitux R 66 Infarct 66 6R BH4 66 pharmacokinetic interactions 66 Cell Lymphoma 66 LymphoStat B TM 66 metastatic gastric 66 Phase IIb Clinical Trial 66 Follicular Lymphoma 66 Aneurysm Repair 66 Adjunctive 66 Bronchial Thermoplasty 66 Resistant Hypertension 66 posaconazole 66 vinca alkaloid 66 AEG# 66 Dose Escalation 66 Malignant Glioma 66 Doripenem 66 Transplant Rejection 66 Immune Mediated 66 nucleotide analogue 66 Elderly Patients 66 Imatinib mesylate 66 nilotinib Tasigna 66 Kidney Function 66 Statistically Significant 66 Hydroxyurea 66 Cloretazine 66 ara C 66 reslizumab 66 Tanezumab 66 monoclonal antibody conjugated 66 TMS Therapy 66 hypervascular tumors 66 pain palliation 66 Novartis Afinitor 66 Unfractionated Heparin 66 alpha 2a 66 hyaluronidase enzyme 66 monoclonal antibody IgG1 Mab 66 aflibercept VEGF Trap 66 VA# [002] 66 Pediatric Patients 66 Systemic lupus erythematosus SLE 66 interstitial cystitis IC 66 Neulasta ® 66 Lymphocytic 66 Controlled Study 66 huC# DM4 66 Juvenile Idiopathic Arthritis 66 Elesclomol 66 NDA Submission 66 vinorelbine tartrate 66 Epilepsy Drug 66 NV1FGF 66 Inhaled nitric oxide 66 microtubule inhibitor 66 calcineurin inhibitor 66 Donepezil 66 LEUKINE 66 Benign Prostatic Hyperplasia BPH 66 Pharmacokinetics PK 66 Inflammatory Diseases 66 Ischemic Stroke 66 Myoblast 66 Factor Receptor 66 aneurysms AAA 66 Benign Prostatic Hyperplasia 66 CTAP# 66 TEMODAL 66 CYP#A# CYP#D# 66 TRANSDUR ® 66 rilonacept 66 Myeloma Patients 66 oncolytic virus therapies 66 Enlarged Prostate 66 Significantly Improved 66 Kepivance 66 leukopenia pancytopenia thrombocytopenia 66 uricase 66 Afinitor everolimus 66 pseudobulbar affect PBA 66 Cytotoxicity 66 Treatment Shows Promise 66 relapsing multiple sclerosis 66 PROCHYMAL 66 Platinol ® 66 thetreatment 66 DOXIL 66 samalizumab 66 cMET 66 Severe Asthma 66 SUTENT ® 66 Pegylated Liposomal Doxorubicin 66 either acutely decompensated 66 ALN HPN 66 Clinical Trial Evaluating 66 Gastric Cancer 66 Drug Combo 66 Chronic Myeloid Leukemia 66 Achieves Primary Endpoint 66 Vorinostat 66 Acute Renal Failure 66 RAPAMUNE 66 Chronic Hepatitis C 66 investigational humanized monoclonal antibody 66 subependymal giant cell 66 Linagliptin 66 Teva Provides Update 66 Erlotinib 66 Pancreas Cancer Vaccine 66 treat chronic sinusitis 66 Cancer Patients Treated 66 Replacement Therapy 66 Hedgehog Pathway Inhibitor 66 cysteamine bitartrate 66 TYGACIL 66 NICE Recommends 66 Xeloda ® 66 Cognitive Impairment 66 colesevelam HCl 66 midstage clinical 66 Novel Compound 66 Cytochrome P# 66 Topotecan 66 Alogliptin 66 XYOTAX TM 66 novel oral anticoagulant 66 hyperphenylalaninemia HPA due 66 Pemphigus 66 Preclinical Efficacy 66 Chronic Heart Failure 66 solifenacin succinate 66 Neovascular Age Related Macular 66 cutaneous T 66 Mimetics 66 SinuNase ™ 66 hyperplasia BPH 66 Knee Osteoarthritis 66 Posaconazole 66 Estrogen Receptor 66 BCG refractory carcinoma 66 Adenoma 66 Roflumilast 66 bone marrow reticulin deposition 66 liposomal formulation 66 ergot derivatives 66 INVANZ 66 Ustekinumab 66 Glivec imatinib 66 Rotavirus Vaccine 66 Cell Lymphoma CTCL 66 Fibrin Patch 66 Disease Modifying 66 Hypotension 66 IMA# 66 Mycamine 66 HDAC Inhibitor 66 PI3K/Akt pathway inhibitor 66 EOquin R 66 Lung Cancer Patients 66 anaphylaxis dyspnea flushing 66 Fingolimod 66 Phase 1b clinical trials 66 fulvestrant 66 MyVax R 66 factor Xa 66 Zolinza 66 mTOR mammalian target 66 Clinical Outcome 66 PrevOnco 66 docetaxel Taxotere R 66 Biolimus A9 66 MEK Inhibitor 66 Proxinium TM 66 icatibant 66 chronic myocardial ischemia 65 Cinacalcet 65 IND Application 65 Ceflatonin R 65 Remicade infliximab 65 Dabigatran 65 R adalimumab 65 mitoxantrone plus 65 histone deacetylase HDAC inhibitor 65 Heterozygous Familial Hypercholesterolemia 65 echinocandin 65 Peripheral Blood 65 Femara letrozole 65 Monoclonal antibody 65 ST Elevation Myocardial 65 5 fluorouracil leucovorin 65 Eluting Coronary Stent System 65 Catheter Ablation 65 Pegylated Interferon 65 Disease Progression 65 visilizumab 65 Ambrisentan 65 rHuPH# recombinant human 65 IMiDs ® 65 Montelukast 65 GAMMAGARD LIQUID 65 Gout Drug 65 Efficacious 65 Cloretazine VNP#M 65 Syndrome LEMS 65 Inflammatory Arthritis 65 PSMA ADC 65 vWD 65 Randomized Clinical Trial 65 diarrhea fatigue asthenia 65 CTAP# Capsules 65 ALVESCO ® 65 EVIZON TM 65 Copegus ® 65 Exemestane 65 KETEK 65 Renal Artery 65 Doxorubicin 65 Aptivus ® 65 Secondary Hyperparathyroidism 65 pregabalin Lyrica 65 Augment TM 65 Demonstrates Significant 65 EVICEL 65 E1 INT TM 65 Levofloxacin 65 TRANSDUR ™ 65 CIMZIA TM certolizumab pegol 65 trastuzumab DM1 T DM1 65 Anti TNF 65 GSK# [002] 65 Pradefovir 65 immunomodulatory therapy 65 Treatment Reduces 65 Atomoxetine 65 Inflammatory Markers 65 vaginal candidiasis 65 Candesartan 65 Nicotine Vaccine 65 Fibrillex TM 65 First Patient Treated 65 Dupuytren Disease 65 Antifungals 65 nucleoside analog 65 Study Showed 65 Dacogen injection 65 Cytarabine 65 aldehyde dehydrogenase ALDH2 deficiency 65 Besivance 65 Node Positive 65 Onconase 65 Raltegravir 65 alefacept 65 Perforomist ™ Inhalation Solution 65 plus DOXIL 65 Cabazitaxel 65 Abbokinase 65 Intravenous Formulation 65 Castration Resistant Prostate Cancer 65 non peptidic protease 65 inhibitor RG# 65 tasocitinib 65 HoFH 65 fluvastatin 65 refractory chronic lymphocytic 65 Darinaparsin 65 Novel Mechanism 65 Phase III Clinical Trials 65 Hormone Receptor Positive 65 Bioral ® 65 Chemokine Receptor 65 Paliperidone ER 65 Myocardial Ischemia 65 candesartan cilexetil 65 Atopic Dermatitis 65 Colorectal Cancer Patients 65 Demonstrated Significant 65 pioglitazone HCl 65 Vascular Grafts 65 von Willebrand Factor 65 Polymerase Inhibitor 65 Fluticasone 65 Camptosar ® 65 solid organ transplantation 65 Combination Therapy 65 Hypertensive Patients 65 Confirms Efficacy 65 Drug Resistant 65 humanized anti 65 rheumatoid arthritis RA psoriatic 65 Novel Therapeutic 65 Left Ventricular 65 ThermoDox R 65 Interferon beta 1b 65 recurrent glioma 65 Oral Mucositis 65 REMINDER ORLive Presents 65 rasagiline tablets 65 noninfectious uveitis 65 Hypercholesterolemia 65 Lanthanum Carbonate 65 acadesine 65 CD# monoclonal antibody 65 p# MAP kinase inhibitor 65 Mylan Receives Approval 65 CIMZIA TM 65 OMP #R# 65 Slows Progression 65 somatostatin analog 65 Carvedilol 65 Resten MP 65 Cimzia TM 65 Clevudine 65 Unresectable 65 SHPT 65 Autoantibodies 65 Oxiplex 65 Breast Cancer Recurrence 65 novel VDA molecule 65 Tumor Necrosis Factor 65 Antifungal 65 Valopicitabine 65 MabCampath 65 Slow Progression 65 sitaxsentan 65 Prodarsan R 65 GRNOPC1 contains 65 Anticonvulsant 65 non nucleoside inhibitor 65 leukemia AML 65 Vicinium TM 65 Diabetic Neuropathic Pain 65 Kidney Transplant Recipients 65 Antiarrhythmic 65 Transcatheter 65 Seliciclib 65 Eluting Stent 65 Darunavir 65 Rheumatoid Arthritis Drug 65 Files IND 65 Budesonide 65 Onyx Pharmaceuticals Announces 65 Gleevec imatinib 65 Valproic acid 65 Interferon beta 1a 65 Synthetic Peptide